High prevalence of circulating myositis-associated antibodies in non-COVID critical illness.
Publication
, Journal Article
Soskis, A; Rice, MB; Bloch, DB; Putman, RK; Rubio, AA; Vera, KZ; Bermea, RS; Sauer, AJ; Sinow, CO; Shen, M; Vera, MP; Baron, RM; Hallowell, RW
Published in: Respir Med Res
June 2024
Duke Scholars
Published In
Respir Med Res
DOI
EISSN
2590-0412
Publication Date
June 2024
Volume
85
Start / End Page
101088
Location
France
Related Subject Headings
- Prevalence
- Myositis
- Middle Aged
- Male
- Humans
- Female
- Critical Illness
- COVID-19
- Autoantibodies
- Aged
Citation
APA
Chicago
ICMJE
MLA
NLM
Soskis, A., Rice, M. B., Bloch, D. B., Putman, R. K., Rubio, A. A., Vera, K. Z., … Hallowell, R. W. (2024). High prevalence of circulating myositis-associated antibodies in non-COVID critical illness. Respir Med Res, 85, 101088. https://doi.org/10.1016/j.resmer.2024.101088
Soskis, Alyssa, Mary B. Rice, Donald B. Bloch, Rachel K. Putman, Antonio Arciniegas Rubio, Katherin Zambrano Vera, Rene S. Bermea, et al. “High prevalence of circulating myositis-associated antibodies in non-COVID critical illness.” Respir Med Res 85 (June 2024): 101088. https://doi.org/10.1016/j.resmer.2024.101088.
Soskis A, Rice MB, Bloch DB, Putman RK, Rubio AA, Vera KZ, et al. High prevalence of circulating myositis-associated antibodies in non-COVID critical illness. Respir Med Res. 2024 Jun;85:101088.
Soskis, Alyssa, et al. “High prevalence of circulating myositis-associated antibodies in non-COVID critical illness.” Respir Med Res, vol. 85, June 2024, p. 101088. Pubmed, doi:10.1016/j.resmer.2024.101088.
Soskis A, Rice MB, Bloch DB, Putman RK, Rubio AA, Vera KZ, Bermea RS, Sauer AJ, Sinow CO, Shen M, Vera MP, Baron RM, Hallowell RW. High prevalence of circulating myositis-associated antibodies in non-COVID critical illness. Respir Med Res. 2024 Jun;85:101088.
Published In
Respir Med Res
DOI
EISSN
2590-0412
Publication Date
June 2024
Volume
85
Start / End Page
101088
Location
France
Related Subject Headings
- Prevalence
- Myositis
- Middle Aged
- Male
- Humans
- Female
- Critical Illness
- COVID-19
- Autoantibodies
- Aged